| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | L A Levine | |
| S M Larsen | |||
| P2860 | cites work | Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba) | Q78663002 |
| Defining the clinical characteristics of Peyronie's disease in young men | Q79325068 | ||
| A new concept in the treatment of Peyronie's disease | Q79534806 | ||
| Intralesional verapamil prevents the progression of Peyronie's disease | Q80485567 | ||
| The use of collagenase in the treatment of Peyronie's disease M.K. Gelbard, A. Lindner, and J.J. Kaufman | Q80863079 | ||
| Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study | Q83039500 | ||
| An analysis of the natural history of Peyronie's disease | Q83335142 | ||
| Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors | Q24683022 | ||
| Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix | Q28378851 | ||
| Microarray analysis of mechanical shear effects on flexor tendon cells | Q28566969 | ||
| Peyronie's disease: experience of local treatment with Orgotein | Q34057229 | ||
| Procarbazine (Natulan) in the treatment of Peyronie's disease | Q34057899 | ||
| The natural history of Peyronie's disease | Q34253179 | ||
| Review of current nonsurgical management of Peyronie's disease | Q34269167 | ||
| Potassium paraaminobenzoate (POTABA) in the treatment of Peyronie's disease: a prospective, placebo-controlled, randomized study | Q34403964 | ||
| Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins | Q34528223 | ||
| Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease | Q34534562 | ||
| FastSize Medical Extender for the treatment of Peyronie's disease | Q34775506 | ||
| A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease. | Q35009905 | ||
| Role of oxidative stress and antioxidants in Peyronie's disease | Q35010227 | ||
| Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts | Q35981915 | ||
| Pentoxifylline attenuates transforming growth factor-β1-stimulated collagen deposition and elastogenesis in human tunica albuginea-derived fibroblasts part 1: impact on extracellular matrix | Q36526721 | ||
| Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial | Q36734258 | ||
| Pharmacological Management of Peyronie's Disease | Q36757584 | ||
| Non-surgical therapy of Peyronie's disease | Q37034999 | ||
| Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. | Q37126137 | ||
| Trauma, gender reassignment, and penile augmentation. | Q37730215 | ||
| Procarbazine-induced hepatotoxicity: case report and review of the literature | Q37735848 | ||
| The management of Peyronie's disease: evidence-based 2010 guidelines | Q37760270 | ||
| Electrical stimulation and wound healing | Q38140766 | ||
| Pentoxifylline attenuates transforming growth factor-beta1-stimulated elastogenesis in human tunica albuginea-derived fibroblasts part 2: Interference in a TGF-beta1/Smad-dependent mechanism and downregulation of AAT1. | Q38269860 | ||
| Is colchicine effective in Peyronie's disease? A pilot study | Q39482557 | ||
| Severe, disabling, and/or chronic penile pain associated with Peyronie disease: management with subcutaneous steroid injection | Q39955030 | ||
| IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease | Q39976615 | ||
| Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses | Q40618953 | ||
| Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial | Q43003227 | ||
| Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report | Q43669319 | ||
| An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. | Q43758174 | ||
| Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease | Q43834212 | ||
| Experience with intraplaque injection of verapamil for Peyronie's disease | Q44072672 | ||
| Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma | Q44413643 | ||
| Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease | Q44461634 | ||
| Peyronie’s Disease: Results with Dermo-Jet Injection of Dexamethasone | Q44792781 | ||
| The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study | Q44934972 | ||
| Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie's plaque fibroblasts | Q45803091 | ||
| Effect of transdermal electromotive drug therapy on fibrogenic cytokine expression in Peyronie's disease. | Q45928511 | ||
| Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study | Q46130680 | ||
| Collagenase versus placebo in the treatment of Peyronie's disease: a double-blind study | Q46329766 | ||
| Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression | Q46755198 | ||
| Peyronie’s Disease: A Study of its Natural History and Treatment with Orthovoltage Radiotherapy | Q46815482 | ||
| The treatment of Peyronie's disease with tamoxifen | Q46941711 | ||
| Intralesional verapamil injection for the treatment of Peyronie's disease. | Q51133527 | ||
| Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. | Q52211310 | ||
| A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie's disease. | Q53193957 | ||
| Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. | Q53230701 | ||
| Profibrotic role of myostatin in Peyronie's disease. | Q54536561 | ||
| Tamoxifen versus placebo in the treatment of Peyronie's disease. | Q55033437 | ||
| Extracorporal Shock Wave Therapy in the Treatment of Peyronie’s Disease | Q58827099 | ||
| ORIGINAL RESEARCH—PEYRONIE'S DISEASE: Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study | Q62660594 | ||
| Induration penis plastica. Experience of treatment with procarbazine Natulan | Q67456885 | ||
| The use of collagenase in the treatment of Peyronie's disease | Q70093615 | ||
| Treatment of Peyronie's disease with local interferon-alpha 2b | Q70824459 | ||
| The non-surgical treatment of Peyronie's disease | Q71353048 | ||
| The biochemical pathway mediating the proliferative response of bone cells to a mechanical stimulus | Q71556362 | ||
| Collagenase for Peyronie's disease experimental studies | Q72962196 | ||
| Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome | Q73112619 | ||
| Immunologic findings in Peyronie's disease: a controlled study | Q73886364 | ||
| Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study | Q74544970 | ||
| Therapeutic effects of colchicine in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study | Q76372661 | ||
| EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction | Q77305048 | ||
| Progressive skin extension: clinical and histological evaluation of a modified procedure using Kirschner wires | Q78210546 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-10 | |
| P577 | publication date | 2011-09-15 | |
| P1433 | published in | International Journal of Impotence Research | Q15749221 |
| P1476 | title | Review of non-surgical treatment options for Peyronie's disease | |
| P478 | volume | 24 |
| Q38206220 | Bacterial collagenases - A review. |
| Q88723514 | Contemporary Review of Peyronie's Disease Treatment |
| Q38742873 | Contemporary Review of Treatment Options for Peyronie's Disease |
| Q38316084 | Corporoplasty using buccal mucosa graft in Peyronie disease: is it a first choice? |
| Q43815027 | Current therapeutic options for Peyronie's disease |
| Q43099012 | Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study |
| Q54262003 | Geometrical modified nesbit corporoplasty to correct different types of penile curvature: description of the surgical procedure based on geometrical principles and long-term results. |
| Q26746129 | Grafting techniques for Peyronie's disease |
| Q38713736 | Innovative surgical techniques for managing Peyronie's disease: a video presentation |
| Q37021450 | Intratunical Injection of Genetically Modified Adipose Tissue-Derived Stem Cells with Human Interferon α-2b for Treatment of Erectile Dysfunction in a Rat Model of Tunica Albugineal Fibrosis |
| Q90613230 | Multi-institutional Prospective Analysis of Intralesional Injection of Collagenase Clostridium Histolyticum, Tunical Plication, and Partial Plaque Excision and Grafting for the Management of Peyronie's Disease |
| Q64245306 | Non-invasive treatment in the management of Peyronie's disease |
| Q44742568 | Penis deviation with or without pain in Peyronie's disease--an update |
| Q38630427 | Peyronie's disease: A contemporary review of non-surgical treatment |
| Q38713713 | Peyronie's disease: contemporary review of non-surgical treatment |
| Q41604964 | Peyronie's graft surgery-tips and tricks from the masters in andrologic surgery |
| Q38451060 | Pharmacologic therapy for Peyronie's disease: what should we prescribe? |
| Q41149177 | Rationale of combination therapy with antioxidants in medical management of Peyronie's disease: results of clinical application |
| Q30382162 | Stromal Vascular Fraction Combined with Shock Wave for the Treatment of Peyronie's Disease |
| Q38062282 | Surgery for Peyronie's disease |
| Q38105323 | Surgical Management for Peyronie's Disease |
| Q45389873 | Surgical therapy of Peyronie's disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new technique |
| Q39143837 | Understanding the cellular basis and pathophysiology of Peyronie's disease to optimize treatment for erectile dysfunction |
Search more.